Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment
Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment
复制标题
DOI:
10.1093/rheumatology/ket189
复制
发表时间:
2013-09-01
期刊:
影响因子:
5.5
通讯作者:
FitzGerald, Oliver
中科院分区:
文献类型:
--
作者:
Collins, Emily S.;Galligan, Marie C.;FitzGerald, Oliver
Methods. Serum samples were collected from 54 IA patients before treatment and at 1 and 12 months after commencing anti-TNF therapy. N-linked glycans from whole serum samples were analysed using a high-throughput hydrophilic interaction liquid chromatography-based method.Results. Glycosylation on the serum proteins of IA patients changed significantly with anti-TNF treatment. We observed an increase in galactosylated glycans from IgG, also an increase in core-fucosylated biantennary galactosylated glycans and a decrease in sialylated triantennary glycans with and without outer arm fucose. This increase in galactosylated IgG glycans suggests a reversing of the N-glycome towards normal healthy profiles. These changes are strongly correlated with decreasing CRP, suggesting a link between glycosylation changes and decreases in inflammatory processes.Conclusion. Glycosylation changes in the serum of IA patients on anti-TNF therapy are strongly associated with a decrease in inflammatory processes and reflect the effect of anti-TNF on the immune system.